BIO-key International
BKYI
12 hedge funds and large institutions have $1.24M invested in BIO-key International in 2022 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 3 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 3
0.01% less ownership
Funds ownership: 0.04% → 0.04% (-0.01%)
3% less capital invested
Capital invested by funds: $1.28M → $1.24M (-$41K)
14% less funds holding
Funds holding: 14 → 12 (-2)
61% less call options, than puts
Call options by funds: $361K | Put options by funds: $918K
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$18.6K |
| 2 |
Simplex Trading
Chicago,
Illinois
|
+$12.1K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$8.08K |
| 4 |
Wolverine Trading
Chicago,
Illinois
|
+$8.08K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$72.3K |
| 2 |
Group One Trading
Chicago,
Illinois
|
-$61K |
| 3 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
-$48K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$8.89K |
| 5 |
CG
Cutler Group
San Francisco,
California
|
-$3.23K |
BKYI Hedge Fund Activity: Q1 2022 in Review
12 of the 6,358 institutional investors tracked by Wall St. Rank reported a position in BIO-key International (BKYI) for Q1 2022, worth a combined $1.24M — down 3.2% from $1.28M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of BKYI and 1 opened new positions — a net loss of 2 holders — while 3 trimmed existing stakes and 3 added.
The largest buyer was Sabby Management, adding an estimated $18.6K. The largest seller was Susquehanna International Group, cutting an estimated $72.3K.
- 12 institutional investors held BIO-key International (BKYI) as of Q1 2022, down from 14 in Q4 2021.
- Funds reported $1.24M of BIO-key International stock for Q1 2022, down 3.2% quarter-over-quarter.
- 1 fund opened new BIO-key International positions in Q1 2022 and 3 closed out, a net change of -2 holders.
- The largest BIO-key International buyer in Q1 2022 was Sabby Management, an estimated $18.6K added.
- The largest BIO-key International seller in Q1 2022 was Susquehanna International Group, an estimated $72.3K sold.
Based on aggregated 13F filings for Q1 2022.